 FRAMINGHAM, Mass., Jan. 17, 2023 GLOBE NEWSWIRE Arch Therapeutics, Inc. OTCQB: ARTH Arch or the Company, a marketer and developer of novel self-assembling wound care and biosurgical products, today announced that it will effect a 1-for-200 reverse stock split of its outstanding and authorized common stock, effective at 5:00 p.m. EST on January 17, ... The post Arch Announces One-for-Two-Hundred Reverse Stock Split in Connection with Application for Uplisting to a National Exchange... 